Xi'an Janssen has been committed to the research and development, introduction and production of high-quality pharmaceuticals and innovative pharmaceutical solutions to meet China's growing medical and health needs. As one of the earliest established multinational pharmaceutical companies and the largest pharmaceutical subsidiary of Johnson & Johnson in China, Xi'an Janssen's products cover psychiatry, neurology, cold and cough and fever/digestion, dermatology/allergy, hematology, immunology, Nine disease areas of solid tumors, infectious diseases and pulmonary hypertension.